Bristol Myers Squibb Soars Into Billion Dollar Roundtable, Elevating Supplier Diversity Initiatives

Reaching new heights, we’ve achieved our goal of investing $1 billion in diverse-owned suppliers – and we’re not stopping there! Our commitment to this important cause expands globally, as we continue to invest in diverse-owned suppliers to drive far-reaching change.

Bristol Myers Squibb (NYSE: BMY) has taken an inspiring stride towards thriving diversity as it is inducted into the Billion Dollar Roundtable, joining other Fortune 100 companies which have invested in minority-owned suppliers. This achievement marks a significant milestone in the company’s long-standing mission to improve health equity, promote an inclusive workplace, diversify clinical trials, and broaden its supplier network.

BMS sprang into action in 2020, setting aspirational inclusion and diversity goals along with health equity commitments that aim to tackle health disparities by 2025. In order to support this mission, the company aimed to spend $1 billion with diverse and minority-owned businesses—and succeeded, achieving the milestone before its 2025 timeline. Undoubtedly, sustaining and building on this success will remain at the forefront of BMS’ agenda.

BMS is committed to creating opportunities, bridging economic gaps, and driving social impact by empowering diverse suppliers. By investing in over 600 diverse suppliers owned by underrepresented groups, women, veterans, LGBTQ+, people with disabilities, and other diverse populations, BMS is not only promoting agility and innovation, but also creating a positive riposte to social determinants of health in diverse communities.

At Bristol Myers Squibb, we remain passionate about driving business priorities and collaborating with industry leaders. As a result of our dedication to this cause, we are proud to announce our investment in an aim to elevate our commitment. With this investment, we are confident that we will continue to make meaningful progress towards our goals.

BMS proudly partners with a range of industry-leading, diverse-owned businesses to extend its operations. Through collaborations with prestigious organizations such as the National Minority Supplier Development Council, Women’s Business Enterprise National Council, National LGBT Chamber of Commerce, Disability IN, and the National Veteran Owned Business Association, BMS is dedicated to making a meaningful impact by promoting economic development, creating wealth, and providing job opportunities for diverse suppliers and communities.

BMS has achieved the prestigious accomplishment of joining the Billion Dollar Roundtable, and they are now looking to take their success even further. By building on this milestone, BMS is striving to reach even greater heights.

At Bristol Myers Squibb, we recognize the importance of inclusion – it’s a core value of our organization. Our commitment to diversity has enabled us to increase our diverse spend, which benefits the communities in which we work, live, and serve. Thanks to strategic partnerships, the positive impact we are making can be seen through our tangible results.

BMS is taking global strides by forging groundbreaking international contracting partnerships, like the one recently established with Minority Supplier Development UK (MSDUK). We are steadfast in believing that supplier diversity is essential to our business growth. Our diverse supplier base helps us to bring innovative solutions to the table, foster economic prosperity, and ultimately create better outcomes for patients and communities worldwide.

Leave a Comment